PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Eine durchschnittliche Folge dieses Podcasts dauert 22m.
Bisher sind 107 Folge(n) erschienen.
Dieser Podcast erscheint alle 3 Wochen.
Gesamtlänge aller Episoden: 1 day 21 hours 21 minutes
Secretory Pituitary Adenomas: What Are the New Treatment Options on the Horizon?
Secretory Pituitary Adenomas: What Are the New Treatment Options on the Horizon?
Stepping Up Care for Acromegaly With Early Diagnosis and Emerging Therapeutic Options
Go online to www.peervoice.com/h/pvr116 to view the entire programme with slides.
Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?
Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?
State of the Science in CKD: New Treatment, New Outcomes
State of the Science in CKD: New Treatment, New Outcomes
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?
Individualising Glycaemic Targets in Type 2 Diabetes and Obesity: A Case-Based Approach
Individualising Glycaemic Targets in Type 2 Diabetes and Obesity: A Case-Based Approach